Product Design, Manufacturing & Innovation Resources
家 » 良好生产规范(GMP)

良好生产规范(GMP)

1960
符合药品生产质量管理规范标准的制药生产设施。

(图片仅供参考)

良好生产规范 (GMP) is a system of regulations and guidelines ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. It covers all aspects of production, from the starting materials, premises, and equipment to the training and personal hygiene of staff. GMP is designed to minimize the risks involved in any pharmaceutical production. GMP compliance is demonstrated in practice through IQ OQ PQ process validation of the equipment and processes.

良好生产规范 (GMP) represents the minimum standard that a medicines manufacturer must meet in their production processes. The core principle of GMP is that quality cannot be tested into a final product; it must be built into the product during all stages of manufacturing. This proactive approach is critical because failures in quality can have life-threatening consequences. GMP guidelines provide a framework for managing production and quality control, often referred to as cGMP, with the ‘c’ standing for ‘current’, emphasizing that the standards must be up-to-date with the latest technology and scientific understanding. Key components of GMP include robust quality management systems, stringent control over raw materials, validated manufacturing processes, and comprehensive documentation. Every step, from receiving raw materials to shipping the final product, must be documented in detail. This creates a traceable batch record that can be audited to ensure compliance and investigate any deviations or product defects. Personnel must be properly trained for their specific roles, and facilities must be designed and maintained to prevent contamination, mix-ups, and errors. Equipment must be calibrated, cleaned, and validated to ensure it performs as intended. Adherence to GMP is enforced by national regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, through regular inspections of manufacturing facilities. Failure to comply can result in product recalls, fines, and even facility shutdowns.

UNESCO Nomenclature: 3308
药房

类型

抽象系统

中断

重大的

用法

广泛使用

前体

  • 1938 年美国联邦食品、药品和化妆品法案,规定上市前必须进行安全审批
  • 20 世纪 50 年代末和 60 年代初的沙利度胺悲剧,凸显了药品监管和检测方面的严重缺陷
  • advances in industrial 过程控制 and quality management theories from other industries

应用程序

  • 处方药和非处方药的生产
  • 生产 疫苗 and biologics
  • 医疗器械制造
  • 活性药物成分(API)的生产
  • 食品和化妆品行业的质量控制

专利:

NA

潜在创新理念

  • implementation of ‘quality by design’ (QbD) principles for proactive quality management
  • 使用过程分析技术(pat)实时监控制造过程
  • 采用连续生产工艺代替传统的批量生产
  • 生产线上的自动化和机器人技术可以减少人为错误
  • 区块链 for secure and transparent supply chain tracking (track and trace)
  • 一次性使用技术,降低交叉污染风险
  • 人工智能驱动的制造设备预测性维护
  • 数字批次记录和电子质量管理系统
  • 先进的无菌产品无菌处理技术
  • GMP条件下个性化剂型的3D打印
相关术语:GMP、cGMP、质量控制、质量保证、药品生产、FDA、法规、药品安全、验证、批次记录。

历史背景

良好生产规范(GMP)

1958
1960
1960
1960
1960
1960
1960
1956
1960
1960
1960
1960
1960
1960
1960

(如果日期未知或不相关,例如“流体力学”,则提供其显著出现的近似估计)

第十年 周年纪念日

只有注册会员才能免费获取完整尺寸的图片和下载内容。

> 登录 <